HB 561 — An Act amending Title 61 (Prisons and Parole) of the Pennsylvania Consolidated Statutes, in Nonnarcotic Medication Assisted Substance Abuse Treatment Grant Pilot Program, further providing for definitions, repealing provisions relating to establishment of pilot program, providing for establishment and further providing for county participation requirements, for use of grant funding, for powers and duties of department, for report to General Assembly and for construction; imposing duties on the Pennsylvania Commission on Crime and Delinquency; and making an editorial change.

PRIOR PRINTER'S NO.

565 PRINTER'STHE NO.GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL Session of No.

1297 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL Session of No.

DAVIS, DALEY, KAZEEM, KOSIEROWSKI, KRAJEWSKI, K.HARRIS, RIVERA, FREEMAN, MAYES, CURRY, PROBST, J.HARRIS,J.HARRIS AND D.

WILLIAMS, BOROWSKI AND YOUNG, FEBRUARY 12, 2025 ASREFERRED REPORTEDTO FROM COMMITTEE ON HUMAN SERVICES, HOUSEFEBRUARY OF12, REPRESENTATIVES, AS AMENDED, APRIL 8, 2025 AN ACT Amending Title 61 (Prisons and Parole) of the Pennsylvania Consolidated Statutes, in Nonnarcotic Medication Assisted Substance Abuse Treatment Grant Pilot Program, further establishmentproviding offor pilotdefinitions, program,repealing providingprovisions forrelating establishmentto and further providing for county participation requirements, for use of grant funding, for powers and duties of department, for prior authorization, for report to General Assembly and for construction;

20250HB0561PN1297 - 2 - § 4602.1.

20250HB0561PN0565 - 2 - The Medication-assisted Substance Abuse Treatment Grant Program is established in the commission to increase opportunities for counties to provide medication-assisted treatment combined with comprehensive substance use DISORDER <-- treatment to eligible offenders while incarcerated and upon release from county correctional institutions.

(1) Assess each offender, prior to reentry into the community, and determine if the offender is a candidate to 20250HB0561PN1297 - 3 - whom should be administered medication that prevents relapse 20250HB0561PN0565 - 3 - to drug dependence or alcohol dependence, or both.

(3) Develop or approve training and instructional materials for the law enforcement community about opioid and 20250HB0561PN1297 - 4 - alcohol addiction and the proper and effective use of 20250HB0561PN0565 - 4 - [nonnarcotic medication assisted substance abuse treatment] medication-assisted treatment in consultation with the appropriate State agencies, including, but not limited to, the Department of Drug and Alcohol Programs, the Department of Human Services, the Department of Health[, the Pennsylvania Board of Probation and Parole and the Pennsylvania Commission on Crime and Delinquency] and the board.

(5) Set forth the basis for medical providers to be reimbursed and for [medical] substance use DISORDER treatment <-- providers to be reimbursed for counseling services.

<-- [Long-acting injectable naltrexone] The following apply:

20250HB0561PN1297 - 5 - (2) Within 90 days of the effective date of this 20250HB0561PN0565 - 5 - [section] paragraph, the Department of Human Services shall issue a bulletin notice to instruct Medicaid managed care plans that approval for the use of [long-acting injectable naltrexone] medication-assisted treatment must be granted if the eligible offenders are enrolled in the [pilot] program upon [their] release from county correctional institutions.

§ 4606.4607.

[PRIOR AUTHORIZATION] MEDICATION-ASSISTED TREATMENT <-- APPROVAL.

[LONG-ACTING INJECTABLE NALTREXONE SHALL BE APPROVED AS PART OF A PRIOR AUTHORIZATION PROCESS BY ANY] A MEDICAID MANAGED CARE PLAN OPERATING UNDER CONTRACT WITH THE COMMONWEALTH FOR ELIGIBLE OFFENDERS ENROLLED IN THE [PILOT] PROGRAM AND RECEIVING COMPREHENSIVE SUBSTANCE [ABUSE] USE DISORDER TREATMENT WHICH INCLUDES THE MONITORING OF MEDICATION ADHERENCE UPON [THEIR] RELEASE FROM COUNTY CORRECTIONAL INSTITUTIONS SHALL APPROVE MEDICATION-ASSISTED TREATMENT FOR FORMS OF SUBSTANCE USE DISORDERS, FROM THE DEPARTMENT OF HUMAN SERVICES' UNIFORM STATEWIDE PREFERRED DRUG LIST, THAT DO NOT REQUIRE PRIOR AUTHORIZATION.

[WITHIN 90 DAYS OF THE EFFECTIVE DATE OF THIS SECTION, THE DEPARTMENT OF HUMAN SERVICES SHALL ISSUE A BULLETIN NOTICE TO INSTRUCT MEDICAID MANAGED CARE PLANS THAT APPROVAL FOR THE USE OF LONG-ACTING INJECTABLE NALTREXONE MUST BE GRANTED IF THE ELIGIBLE OFFENDERS ARE ENROLLED IN THE PILOT PROGRAM UPON THEIR RELEASE FROM COUNTY CORRECTIONAL INSTITUTIONS.] § 4607.

[Within 18 months of the effective date of this section, the department] (a) Issuance.--Beginning two years after the effective date of this subsection, the commission shall issue a biennial report to the Judiciary Committee of the Senate and the 20250HB0561PN1297 - 6 - Appropriations Committee of the Senate and the Judiciary Committee of the House of Representatives and the Appropriations Committee of the House of Representatives evaluating the effectiveness of the [pilot] program.

[(5) The number of providers available to meet the requirements provided in section 4603 (relating to county participation requirements) on a county-by-county basis.] (6) The impact of the use of [long-acting nonnarcotic, 20250HB0561PN0565 - 6 - nonaddictive medication assisted] medication-assisted treatment on treatment outcomes and any potential cost savings.

20250HB0561PN129720250HB0561PN0565 - 7 -